HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway

Wen-Ke Wang1, Qing-Hua Lu, Jia-Ning Zhang

  • 1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Insights

High mobility group box 1 protein (HMGB1) inhibition protects against high glucose-induced cardiomyocyte apoptosis. HMGB1 reduction decreases cell death by down-regulating extracellular signal-regulated kinase (ERK) and Ets-1 signaling pathways.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Diabetology

Background:

  • Diabetic cardiomyopathy involves cardiomyocyte apoptosis.
  • High mobility group box 1 protein (HMGB1) expression increases in diabetic conditions.
  • The mechanism of high glucose (HG)-induced cardiomyocyte apoptosis is not fully understood.

Purpose of the Study:

  • To investigate the role of HMGB1 in high glucose (HG)-induced cardiomyocyte apoptosis.
  • To elucidate the molecular mechanism underlying HG-induced cardiomyocyte apoptosis.

Main Methods:

  • Primary cardiomyocytes were treated with HG and HMGB1 was inhibited using short-hairpin RNA.
  • Caspase-3 activation and the ratio of Bcl2-associated X protein to B-cell lymphoma/leukemia-2 (bax/bcl-2) were measured.
  • Extracellular signal-regulated kinase 1/2 (ERK1/2) and Ets-1 activation were assessed in vitro and in vivo using streptozotocin-induced diabetic mice.

Main Results:

  • HG treatment increased cardiomyocyte apoptosis and HMGB1 levels.
  • HMGB1 inhibition reduced HG-induced apoptosis by decreasing caspase-3 activation and altering the bax/bcl-2 ratio.
  • HMGB1 inhibition attenuated HG-induced activation of Ets-1 via the ERK1/2 pathway.
  • Inhibition of Ets-1 also decreased HG-induced cardiomyocyte apoptosis.
  • Similar protective effects of HMGB1 inhibition were observed in diabetic mice, reducing myocardial apoptosis and ERK/Ets-1 activation.

Conclusions:

  • HMGB1 plays a critical role in high glucose-induced cardiomyocyte apoptosis.
  • Inhibition of HMGB1 may offer a therapeutic strategy against hyperglycaemia-induced cardiac damage.
  • The protective mechanism involves the down-regulation of ERK-dependent Ets-1 activation.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
23
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
11
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K